Annual Report

Overview

The report describes Xspray Pharma's 2022 as a pre-commercial development year focused on advancing XS004/Dasynoc and XS003, with preparations for a US launch. The Group had 27 employees at year-end and no net sales, while its sustainability agenda emphasized responsible procurement, energy efficiency, waste reduction, and patient health and well-being.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2022
Period: 1 January 2022 – 31 December 2022
Publication date: 28 March 2023
Language: English
Pages
File size
Restatement: Disclosed

Standards

Other

Materiality

Assessment
Basis

Assurance

Statement included

Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services